The University of Chicago Header Logo

Connection

James J. Curran to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications James J. Curran has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.302
  1. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol. 2005 Aug; 11(4):213-5.
    View in: PubMed
    Score: 0.196
  2. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Clin Dermatol. 2007 May-Jun; 25(3):341-6.
    View in: PubMed
    Score: 0.055
  3. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum. 2005 Oct 15; 53(5):788-91.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.